Can I restart after stopping because of side effects
HbA1c staying above target despite metformin Overweight or obesity, especially the abdominal fat pattern common in Indians Existing cardiovascular disease or high cardiac risk a topic we cover in depth in Part 8: GLP-1, Heart and Kidney Benefits Chronic kidney disease, where GLP-1 drugs have shown protective signals [7] A need to avoid hypoglycemia or further weight gain, which older drugs like sulfonylureas often cause DPP-4 inhibitors such as teneligliptin, sitagliptin, vildagliptin, and linagliptin are widely prescribed in India and lower blood glucose with a low risk of hypoglycemia
Ann Cardiothorac Surg 6(2):144-151, 2017
Essentially, the body is comfortable with the drug, and when it is discontinued, the body struggles to rebalance itself without it
Semaglutide has been approved to treat MASH on the condition that further results from an ongoing study in adults with MASH and moderate to advanced liver scarring will be submitted
Spitz FR, Kataoka M, Sarkiss M, Meyn R, McDonnell TJ, Swisher S , Cristiano RJ, Roth JA
.webp)
